Remove Acquisition Remove Layoffs Remove Report Remove San Diego
article thumbnail

Amylin Pharmaceuticals To Shut San Diego Operations

socalTECH

However, it looks like the acquisition of San Diego''s Amylin Pharmaceuticals by Bristol-Myers Squibb is turning out not-so-great for employees in the location, after news that Bristol-Myers Squibb plans to close its San Diego operations , resulting in the loss of hundreds of jobs. READ MORE>>.

San Diego 153
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

—The Institute for Clinical and Economic Review (ICER), whose drug-value analyses set the pharma industry’s teeth on edge , issued a new report on PD-1 inhibitors , part of the first wave of cancer immunotherapy drugs to be approved. In December we’ll gather in San Francisco to discuss the U.S. PRICE FIGHTS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster. —Buzzfeed ran a lengthy report Wednesday on the sexual harassment charges against University of Washington vaccine researcher Michael Katze.

article thumbnail

Xconomy’s Top Innovation Stories of the Half Year

Xconomy

Layoffs Reflect New Turbulence at High-Flying 3D Robotics. Frank Vinluan reports from North Carolina on a new effort to boost agtech startups and university research. Jeff Engel maps out New England’s cluster of cybersecurity companies—one of the region’s strengths (and a rich source of acquisition targets).